Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „week“
Suchtreffer
Begriffe & Kennungen
Capecitabine Medac · 4.8 · HFS (see section 4.4) For the capecitabine dose of 1,250 mg/m² twice daily on days 1 to 14 every 3 weeks, a fr
Eintrag öffnenCapecitabine Teva · 4.8 · For the capecitabine dose of 1250 mg/m2 twice daily on days 1 to 14 every 3 weeks, a frequency of 53% to 60% o
Eintrag öffnenCasgevy · 4.5 · Discontinue the use of voxelotor and crizanlizumab at least 8 weeks prior to start of mobilisation and conditi
Eintrag öffnenCasgevy · 4.5 · Use of hydroxyurea/hydroxycarbamide must be discontinued at least 8 weeks prior to start of mobilisation and c
Eintrag öffnenCatiolanze · 4.8 · In two short term clinical trials (≤12 weeks), involving 93 (25 and 68) paediatric patients treated with prese
Eintrag öffnenCelsentri · 4.8 · Delayed type hypersensitivity reactions, typically occurring within 2-6 weeks after start of therapy and inclu
Eintrag öffnenCelsentri · 4.8 · Delayed type hypersensitivity reactions, typically occurring within 2-6 weeks after start of therapy and inclu
Eintrag öffnenCelsentri · 4.8 · The MOTIVATE studies were extended beyond 96 weeks, with an observational phase extended to 5 years in order t
Eintrag öffnenCelsentri · 4.8 · The MOTIVATE studies were extended beyond 96 weeks, with an observational phase extended to 5 years in order t
Eintrag öffnenCelsentri · 4.8 · The adverse reaction profile in paediatric patients is based on 48 Week safety data from study A4001031 in whi
Eintrag öffnenCelsentri · 4.8 · The adverse reaction profile in paediatric patients is based on 48 Week safety data from study A4001031 in whi
Eintrag öffnenChenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau) · 4.8 · The only infant enrolled presented with raised liver function tests within six weeks of treatment start. The i
Eintrag öffnenCholib · 4.8 · 11 Tabulated list of adverse reactions During four double blind clinical trials of 24-week duration 1,237 pati
Eintrag öffnenCholib · 4.8 · Tabulated list of adverse reactions During four double blind clinical trials of 24-week duration 1,237 patient
Eintrag öffnenCibinqo · 4.8 · Creatine phosphokinase elevations (CPK) In placebo-controlled studies, for up to 16 weeks, significant increas
Eintrag öffnenCibinqo · 4.8 · In placebo-controlled studies, for up to 16 weeks, the rate of serious infections was 1.81 per 100 patient-yea
Eintrag öffnenCibinqo · 4.8 · Infections In placebo-controlled studies, for up to 16 weeks, infections have been reported in 27.4% of patien
Eintrag öffnenCibinqo · 4.8 · Lipid elevations In placebo-controlled studies, for up to 16 weeks, there was a dose-related increase in low-d
Eintrag öffnenCibinqo · 4.8 · Lymphopenia In placebo-controlled studies, for up to 16 weeks, confirmed ALC < 0.5 × 103/mm3 occurred in 0.3%
Eintrag öffnenCibinqo · 4.8 · Nausea In placebo-controlled studies, for up to 16 weeks, nausea was reported in 1.8% of patients treated with
Eintrag öffnen